BECTON DICKINSON & CO (BDX)
BD subsidiary issued €600 million in senior unsecured notes with full guarantee from the parent company to refinance existing debt and fund general corporate purposes.
View raw filing on EDGAR →SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
BD subsidiary issued €600 million in senior unsecured notes with full guarantee from the parent company to refinance existing debt and fund general corporate purposes.
View raw filing on EDGAR →The filing discloses James Hardie's fiscal year 2026 Irish Statutory Accounts furnished under Item 7.01 (Regulation FD Disclosure). While this represents audited financial statements that would normally constitute an earnings release, the disclosure is explicitly furnished under Regulation FD rather than filed as a formal earnings announcement (Item 2.02), and the prose emphasizes non-filing status and liability disclaimers. This hybrid treatment—statutory accounts disclosed via FD rather than as a traditional earnings release—does not fit cleanly into the earnings_release category and is best classified as other_material given its materiality to investors assessing the registrant's financial position.
View raw filing on EDGAR →Avista Corp. entered into a material definitive agreement and created a direct financial obligation through the issuance of $160 million in first mortgage bonds ($90 million due 2029 at 4.77% and $70 million due 2056 at 6.10%), with an additional $70 million expected in August 2026, for refinancing and capital expenditure purposes.
View raw filing on EDGAR →The filing discloses elimination of an entire class of preferred stock (Series B Preferred Stock) via Certificate of Elimination following redemption of all outstanding shares on May 15, 2026. While this is a corporate governance/capital structure event rather than a specific taxonomy category, the redemption and elimination of a preferred stock class materially affects the registrant's capitalization and is disclosed under Item 5.03. This does not fit cleanly into earnings, executive changes, M&A, impairment, or other more specific event types, warranting classification as other_material.
View raw filing on EDGAR →The filing discloses termination of a Cooperation Agreement between Entravision and the Stockholders (widow of former CEO Walter Ulloa and related trusts) that had governed board nomination rights and stockholder commitments since May 2023. While the termination itself is administrative, the agreement involved material governance arrangements and a significant shareholder relationship tied to the company's former leadership. The event does not fit neatly into the specific taxonomy categories (not an M&A activity, not a covenant breach, not a going-concern issue), making "other_material" the most appropriate classification for this governance-related termination.
View raw filing on EDGAR →The filing discloses a quarterly shareholder update for Q1 2026 under Item 7.01 (Regulation FD Disclosure), furnished but not filed. While this is a routine quarterly communication to shareholders, it does not fit the earnings_release category (which typically involves formal financial results as a press release exhibit) nor any other specific event type. The update would be material to shareholders assessing fund performance and status, warranting classification as other_material rather than a more specific category.
View raw filing on EDGAR →Lumen announced early results of cash tender offers for approximately $750 million in outstanding debt across multiple subsidiaries and note series. While debt repurchase activity can signal financial management or refinancing strategy, this disclosure does not fit cleanly into the more specific event categories (not M&A, not a covenant breach, not a restatement or going-concern issue). The tender offer itself—a material debt reduction initiative—is a significant corporate action affecting the capital structure and financial obligations of the registrant, warranting classification as a material event outside the standard taxonomy.
View raw filing on EDGAR →American Water's finance subsidiary closed a $500 million senior notes offering on May 20, 2026, with net proceeds of approximately $498 million. While this is a material financing event that would affect investor assessment of the company's capital structure and liquidity, it does not fit cleanly into the dilutive_issuance category (which typically applies to equity securities or convertibles) nor any other more specific event type. The disclosure centers on debt issuance and refinancing activity rather than a discrete material event like M&A, impairment, or covenant breach.
View raw filing on EDGAR →The filing discloses the Company's Net Asset Value (NAV) per share as of April 30, 2026, across six classes of common shares and OP Units, calculated in accordance with board-approved valuation guidelines. While NAV reporting is a routine disclosure for REITs and non-traded funds, the detailed breakdown of NAV components and per-share values across multiple share classes would be material to investors evaluating the fund's performance and share pricing. This does not fit neatly into the more specific event categories (not earnings, not an executive change, not M&A, etc.), making "other_material" the most appropriate classification.
View raw filing on EDGAR →This disclosure reports the Company's Net Asset Value (NAV) per share as of April 30, 2026, broken down by share class, along with a detailed calculation of total NAV and its components. For a non-traded REIT like Fortress Credit Realty Income Trust, NAV per share is a critical valuation metric that directly informs investor pricing and redemption decisions. While this is a routine periodic disclosure for REITs, it is material to investors assessing the registrant's asset value and performance. The filing does not fit neatly into more specific event categories (not earnings, not M&A, not impairment, etc.), making "other_material" the most appropriate classification.
View raw filing on EDGAR →The Centers for Medicare & Medicaid Services expanded Medicare coverage for Personalis's NeXT Personal® test to include a new clinical indication (monitoring treatment response to neoadjuvant therapy in Stage II-III breast cancer patients). This regulatory approval expands the addressable market and revenue potential for a key product, which is material to investors. However, the event does not fit neatly into more specific categories (not an earnings release, M&A activity, impairment, or litigation), so it is classified as other_material.
View raw filing on EDGAR →Sotera Health entered into Amendment No. 7 to its First Lien Credit Agreement on May 20, 2026, refinancing approximately $1.42 billion in term loans with a 0.25% reduction in interest rate spread and extending maturity to May 30, 2031.
View raw filing on EDGAR →Wesbanco's Board approved a new stock repurchase program authorizing up to 4.0 million shares, which is a material capital allocation decision affecting shareholder value and future earnings per share. While this is a routine corporate governance action, the authorization of a substantial share buyback program would affect a reasonable investor's assessment of the company's capital strategy and financial position, making it material despite not fitting neatly into more specific event categories.
View raw filing on EDGAR →Eli Lilly completed a substantial $8.94 billion debt offering across eight series of notes with varying maturities and interest rates, including a contingent mandatory redemption provision tied to the Centessa Acquisition. While this is a material financing event affecting the company's capital structure and liquidity, it does not fit neatly into the standard 8-K taxonomy (not an earnings release, M&A completion, impairment, or other specifically enumerated event type). The disclosure is material to investors as it reflects significant new debt obligations and conditional redemption terms dependent on an acquisition outcome.
View raw filing on EDGAR →Williams Companies entered into two material credit agreements on May 19, 2026: a Second Amended and Restated Credit Agreement ($3.75 billion aggregate commitment with $500 million expansion option) and a 364-Day Credit Agreement ($1.0 billion aggregate commitment with $150 million expansion option). These agreements establish the company's primary liquidity facilities and contain financial covenants (debt-to-EBITDA ratio of 5.00:1.00).
View raw filing on EDGAR →The disclosure announces positive Phase 3 and Phase 2 clinical trial data presented at a major medical congress. While this represents material clinical progress for a biopharmaceutical company that could affect investor assessment of pipeline value and regulatory prospects, it does not fit the earnings_release category (which typically applies to financial results) nor any other more specific event type. The clinical data announcement is material but best classified as other_material given the taxonomy's focus on financial and corporate governance events.
View raw filing on EDGAR →This Item 7.01 Regulation FD Disclosure contains a Q&A addressing material business developments: Middle East disruption impacts, significant growth in customs brokerage driven by tariff refunds and regulatory complexity, AI/technology investments enhancing margins, and hyperscaler volume trends. While the disclosure is primarily forward-looking guidance and management commentary rather than a discrete event (M&A, restatement, departure, etc.), the substantive discussion of customs growth drivers, tariff refund activity, and technology initiatives would affect a reasonable investor's assessment of the company's near-term revenue and margin trajectory. This does not fit neatly into the more specific event categories but is material disclosure under Regulation FD.
View raw filing on EDGAR →Wells Fargo issued $6 billion in Medium-Term Notes (Series Y) across three tranches on May 20, 2026, with maturities in 2029 and 2032. This is a material debt issuance disclosed under Item 9.01 (Financial Statements and Exhibits) rather than a dedicated 8-K Item, making it a material financing event that does not fit neatly into the standard taxonomy categories. The filing documents the note forms and legal opinion, indicating a significant capital markets transaction.
View raw filing on EDGAR →All In FutureTech Alliance, Inc. (formerly Allied Gaming & Entertainment Inc.) completed a strategic review process and executed a corporate rebranding, including a name change effective May 15, 2026, and a new NASDAQ ticker symbol 'AIFA' effective May 19, 2026, with corresponding amendments to its Certificate of Incorporation and bylaws.
View raw filing on EDGAR →VStock Transfer was terminated and Odyssey Transfer and Trust Company was appointed as the new exchange agent, transfer agent, and registrar, effective April 28, 2026.
View raw filing on EDGAR →This disclosure announces the commencement of separate trading of Class A Ordinary Shares and Warrants previously bundled in Units, effective May 20, 2026. While this is a routine structural event for a SPAC, the ability to separately trade components affects the capital structure and liquidity profile available to investors, making it material to security holders. The event does not fit neatly into more specific categories (not M&A, not a dilutive issuance, not an impairment), so other_material is most appropriate.
View raw filing on EDGAR →The 8-K discloses a shareholder letter regarding "strategy overview and business update" filed under Item 8.01 (Other Events). Without access to the actual letter content (Exhibit 99.1), the materiality and specific event type cannot be definitively determined. The filing itself provides no substantive disclosure of the strategy or business update, making it impossible to classify into a more specific category. This is classified as other_material with moderate confidence, pending review of the attached exhibit.
View raw filing on EDGAR →The Shareholder Letter references an ongoing warrant exchange offer (pursuant to a Schedule TO filed January 23, 2026) and an ongoing bridge financing under Regulation D, both material to the company's capital structure and financing strategy.
View raw filing on EDGAR →MVB Financial Corp. announced a quarterly cash dividend of $0.17 per share, representing a material disclosure of capital allocation to shareholders.
View raw filing on EDGAR →The Company disclosed achievement of Milestone 1 under a Contingent Value Right Agreement, triggering a direct financial obligation to pay approximately $33.4 million ($0.50 per CVR) in cash within 20 business days. While this is a material cash obligation disclosed under Item 2.03, it does not fit cleanly into the more specific event categories (it is neither a covenant breach, debt issuance, nor a traditional financial obligation like a loan). The CVR payment obligation is a contingent consideration from a prior transaction, making "other_material" the most appropriate classification.
View raw filing on EDGAR →The company extended the maturity date of its Series C Convertible Redeemable Preferred Stock by one year to February 28, 2028, following majority shareholder approval and formalization via Certificate of Amendment filed with the Texas Secretary of State. This modification to the preferred stock terms materially affects the capital structure and investor rights of preferred shareholders.
View raw filing on EDGAR →The filing discloses a shareholder letter from the CEO posted on May 20, 2026, providing "updates regarding the Company's business and business plans." The forward-looking statements reference material project financing, pipeline construction milestones, regulatory developments, and technology commercialization at ATEC and Cadiz Ranch. While the specific content of the letter is not provided in the Item 7.01 disclosure itself, the CEO's public communication of business updates and strategic plans constitutes a material disclosure under Regulation FD. This does not fit neatly into the more specific event categories (no earnings release, M&A, executive change, or financial restatement is indicated), making "other_material" the appropriate classification.
View raw filing on EDGAR →cbdMD entered into a Third Amendment to Lease on May 20, 2026, extending its warehouse and executive office facility lease by 62 months through November 2031 with a reduced footprint and materially lower rent, generating approximately $100,000–$120,000 in annual net rent expense reduction. The amendment creates a direct financial obligation under the extended lease terms and is operationally significant for the company's long-term occupancy and operating expenses.
View raw filing on EDGAR →Brand Engagement Network Inc. disclosed the grant of U.S. Patent No. 12,633,027 titled "Systems and Methods for Gesture Generation From Text" to its subsidiary Datum Point Labs on May 19, 2026. The company describes this as supporting its core AI technology capability for generating lifelike gestures from avatars and enabling real-time user interaction. While the filing does not fit neatly into standard 8-K event categories (earnings, M&A, executive changes, etc.), a material patent grant for a technology-dependent company's core product functionality would reasonably affect an investor's assessment of the registrant's competitive position and intellectual property portfolio, warranting disclosure as a material event under Item 8.01.
View raw filing on EDGAR →Telomir Pharmaceuticals disclosed publication of a peer-reviewed preclinical study on its lead candidate Telomir-1 in Wilson's disease, demonstrating positive efficacy signals including reductions in oxidative stress, hepatic copper accumulation, and improvements in survival outcomes. While this is a positive development for a clinical-stage biotech company, it does not fit neatly into the standard 8-K taxonomy—it is neither an earnings release (no financial results), nor an executive change, M&A activity, or other discrete event type. The disclosure is material to investors evaluating the company's pipeline prospects, warranting classification as other_material.
View raw filing on EDGAR →The filing discloses that the U.S. Nuclear Regulatory Commission has formally accepted Nano Nuclear Energy's Construction Permit Application for deployment of its KRONOS MMR™ at the University of Illinois Urbana-Champaign. This is a significant regulatory milestone for a nuclear technology company, indicating progress toward commercialization of a key product. While this does not fit neatly into the standard event taxonomy (not an earnings release, M&A activity, executive change, or other enumerated categories), it is material to investors as it represents a major regulatory approval that affects the company's ability to execute its business plan.
View raw filing on EDGAR →The Company determined that interest on its 7.00% Subordinated Convertible Notes due 2031 will be paid in Series D Cumulative Convertible Preferred Stock rather than cash on the June 30, 2026 payment date. This represents a material change in the form of debt service that signals potential liquidity constraints and affects the economic terms of the convertible notes for investors, but does not fit neatly into the more specific event categories (not a covenant breach, restatement, or going-concern disclosure, though it may be a precursor to such events).
View raw filing on EDGAR →The filing discloses a change in special servicer for the Bravern Office Commons mortgage loan securitization, with Torchlight Loan Services replacing KeyBank National Association effective May 20, 2026. While this is an administrative change in loan servicing roles, it involves a material securitized asset and could signal concerns about loan performance or servicer capability. However, it does not fit cleanly into the standard taxonomy categories (not an M&A activity, covenant breach, or impairment), warranting classification as other_material.
View raw filing on EDGAR →This Item 8.01 discloses the closing and issuance of commercial mortgage pass-through certificates (Benchmark 2026-B43 Mortgage Trust) on May 20, 2026, with approximately $661.3 million in aggregate principal amount across public and private offerings. While this is a material securitization event involving significant capital raising and mortgage loan acquisition, it does not fit neatly into the standard 8-K taxonomy categories (not an earnings release, M&A activity, impairment, or other specifically enumerated events). The disclosure centers on the completion of a structured finance transaction rather than a discrete corporate action.
View raw filing on EDGAR →The Company created 35,000 authorized shares of Series C Convertible Preferred Stock with a 2% quarterly preferred return (8% annualized), senior liquidation preferences, conversion rights, and extensive operational covenants requiring majority holder consent for asset dispositions over $500,000, reverse splits, and new preferred issuances.
View raw filing on EDGAR →AMASS BRANDS completed a direct listing of its Common Stock on the Nasdaq Global Market, a significant capital markets event marking the company's transition to public trading.
View raw filing on EDGAR →OPAL Fuels approved an Amended and Restated Certificate of Designations for Series A-1 Preferred Units on May 18, 2026, materially modifying the rights of preferred security holders. Key changes include: dividend rate increase from 8% to 12% per annum, restructured payment-in-kind provisions, revised Change of Control definition, new Trigger Event framework with penalty rates, removal of delayed redemption conversion rights, and expanded protective provisions. While Item 3.03 addresses material modifications to security holder rights, this disclosure does not fit neatly into the more specific event categories (it is not an appointment, departure, compensation arrangement, M&A activity, or other enumerated event type), making "other_material" the most appropriate classification for a material amendment to preferred unit terms.
View raw filing on EDGAR →Black Rock Coffee Bar entered into an irrevocable proxy agreement on May 15, 2026, granting the Company and its CEO voting authority over Class A, B, and C shares held by founder investors for up to two years, representing a material governance restructuring affecting shareholder voting control.
View raw filing on EDGAR →PEDEVCO entered into a Third Amendment to its Credit Agreement on May 19, 2026, increasing the borrowing base and elected commitment amount from $120 million to $125 million, creating a direct financial obligation and modifying the company's credit facility terms.
View raw filing on EDGAR →The filing discloses a declared distribution of cash to shareholders across five classes of common stock, with net distributions ranging from $0.0442 to $0.0572 per share after deducting advisory and servicing fees. While distribution declarations are routine for REITs, this disclosure under Item 7.01 (Regulation FD Disclosure) rather than a dedicated Item suggests it may be material information for investors assessing dividend yield and capital returns, though it does not fit neatly into the standard event taxonomy categories.
View raw filing on EDGAR →The disclosure announces a 1-for-8 reverse stock split effective May 22, 2026, with trading to resume on a split-adjusted basis under the same ticker "LNAI" on Nasdaq Capital Market. While reverse splits are material corporate actions affecting share structure and investor holdings, this filing does not fit the more specific event categories (delisting_risk, dilutive_issuance, or other defined types). The reverse split itself is a material event that would affect a reasonable investor's assessment of share value and capital structure, warranting classification as other_material.
View raw filing on EDGAR →Shareholders approved a corporate name change from 'Investcorp AI Acquisition Corp.' to 'Libity' and an extension of the business combination deadline from May 12, 2027 to May 12, 2028, with 99.6% of outstanding shares voting in favor. Following the extension, 11,896 Class A ordinary shares were redeemed by shareholders, with proceeds drawn from the trust account.
View raw filing on EDGAR →This Item 8.01 disclosure covers multiple routine fund operations: a declared dividend of $0.20 per Class I Share, net asset value reporting ($25.76 per share, $104.2 million total), portfolio composition (39 companies, $215.7 million fair value), and ongoing public offering status. While dividend declarations and NAV updates are standard for closed-end funds and typically immaterial, the combination of material portfolio metrics, leverage ratios (1.15x debt-to-equity), and continuous offering activity could affect investor assessment. However, no single event (earnings, impairment, covenant breach, or executive change) fits the specific taxonomy, making "other_material" the most appropriate classification for this routine but comprehensive fund update.
View raw filing on EDGAR →FB Bancorp completed a stock repurchase program that retired 10% of outstanding shares at an average price of $13.717 per share. While share repurchases are capital allocation events that affect shareholder equity and EPS, they do not fit neatly into the more specific event categories (not an earnings release, M&A, impairment, or executive change). This is material to investors as it reflects management's capital deployment strategy and impacts share count, but lacks a dedicated taxonomy entry.
View raw filing on EDGAR →American Tower Corporation announced the pricing of a €750 million registered public offering of senior unsecured notes due 2033 at 4.000% per annum. This is a material debt issuance that would affect investor assessment of the company's capital structure and financing activities, but it does not fit neatly into the more specific event categories (it is neither a dilutive equity issuance under Item 3.02, nor an M&A activity, nor a covenant breach). The disclosure is appropriately classified as other_material.
View raw filing on EDGAR →The filing discloses a material amendment to a $4.5M revolving credit facility that extends the maturity date and imposes new restrictive covenants requiring refinancing by September 15, 2026 or face a $15,000 failure-to-perform fee and default. While this is a debt covenant modification, the language does not indicate a breach or acceleration of existing obligations—rather, it is a negotiated extension with new conditions. This does not cleanly fit "covenant_breach" (which typically signals a triggering event causing acceleration) but represents a material modification to the company's financing arrangements that would affect investor assessment of liquidity and financial flexibility.
View raw filing on EDGAR →Upon IPO closing on May 18, 2026, the Company's amended and restated certificate of incorporation and bylaws became effective, establishing the governance framework for the newly public entity.
View raw filing on EDGAR →PSB Financial announced the expected closing of a mutual-to-stock conversion and related initial public offering on May 21, 2026, with OTCQB listing to commence May 22, 2026. While this is a significant corporate transformation event affecting the company's ownership structure and public status, it does not fit neatly into the standard M&A taxonomy (ma_activity typically covers acquisitions, dispositions, mergers, or changes of control involving another entity). The conversion and IPO are material to investors but represent a structural reorganization distinct from traditional M&A.
View raw filing on EDGAR →NBT Bancorp's Board of Directors approved a quarterly cash dividend of $0.37 per share, with specified payment and record dates, representing a material capital allocation decision for shareholders.
View raw filing on EDGAR →Korro Bio announced the addition of KRRO-111 for Alpha-1 Antitrypsin Deficiency to its pipeline, disclosed via press release and updated investor presentation. While this represents a material pipeline expansion for a clinical-stage biotech company that would affect investor assessment of the company's development strategy and future prospects, it does not fit neatly into the more specific event categories (not an earnings release, M&A activity, impairment, or other defined event types). This is best classified as other_material.
View raw filing on EDGAR →